MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

Major Program
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
ECOG-ACRIN Cancer Research Group
Active, not recruiting ID
For more information, see NCT02352883
This clinical trial studies magnetic resonance imaging (MRI) and gene expression in diagnosing patients with abnormal cells in the breast duct that have not spread outside the duct. MRI uses radio waves and a powerful magnet linked to a computer to create detailed pictures of areas inside the body. MRI may help find and diagnose patients with breast cancer. It may also help doctors predict a patient's response to treatment and help plan the best treatment. Genetic studies may help doctors predict the outcome of treatment and the risk for disease recurrence. Performing MRI with genetic studies may help determine the best treatment for patients with breast cancer in situ.
Cytology Specimen Collection Procedure, Endocrine Therapy, Laboratory Biomarker Analysis, Magnetic Resonance Imaging, Quality-of-Life Assessment, Radiation Therapy, Therapeutic Conventional Surgery, Therapeutic Surgical Procedure
Ductal Breast Carcinoma In Situ
Constance Lehman

See list of participating sites